Dr. med. Dieter Köberle
Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study
Ruhstaller T, Böhme C, Hess D, Hoefliger M, Mueller U, Köberle D, Spaeti B, Glaus A, Ribi K, Rufibach K, von Moos R, Thürlimann B. Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study. Oncology 2009; 76:142-8.
01.01.2009Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study
01.01.2009Oncology 2009; 76:142-8
Ruhstaller Thomas, Böhme Christel, Hess Dagmar, Hoefliger Markus, Mueller Urs, Köberle Dieter, Spaeti Bruno, Glaus Agnes, Ribi Karin, Rufibach Kaspar, von Moos Roger, Thürlimann Beat
Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom
Baumann M, Weder P, Köberle D. Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom - Bewertung der aktuellen Studeienresultate und Konsequenzen. Schweizer Zeitschrift für Onkologie 2009:14-19.
01.01.2009Neue Behandlungsoptionen beim metatstasierten Kolorektalkarzinom
01.01.2009Schweizer Zeitschrift für Onkologie 2009:14-19
Baumann Michael, Weder Patrik, Köberle Dieter
Concordant colon tumors in monozygotic twins previously treated for prostate cancer
Templeton A, Marra G, Valtorta E, Heinimann K, Müller H, Köberle D, Gillessen Sommer S. Concordant colon tumors in monozygotic twins previously treated for prostate cancer. Familial cancer 2009; 8:167-71.
01.01.2009Concordant colon tumors in monozygotic twins previously treated for prostate cancer
01.01.2009Familial cancer 2009; 8:167-71
Templeton Arnoud, Marra Giancarlo, Valtorta Emanuele, Heinimann Karl, Müller Hansjakob, Köberle Dieter, Gillessen Sommer Silke
Between utter despair and essential hope
Renz M, Köberle D, Cerny T, Strasser F. Between utter despair and essential hope. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:146-9.
01.01.2009Between utter despair and essential hope
01.01.2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:146-9
Renz Monika, Köberle Dieter, Cerny Thomas, Strasser Florian
Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
Köberle D, Rust C, Bieri G, Neuweiler J, Terraciano L, Ruhstaller T, Heitzmann F, Hess V, Winterhalder R, von Moos R, Burkhard R, Toepfer M. Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. British journal of cancer 2008; 98:1204-9.
08.04.2008Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
08.04.2008British journal of cancer 2008; 98:1204-9
Köberle Dieter, Rust C, Bieri G, Neuweiler Jörg, Terraciano L, Ruhstaller Thomas, Heitzmann F, Hess V, Winterhalder R, von Moos R, Burkhard R, Toepfer M
Dermatologische Nebenwirkungen der EGFR-Inhibitoren
Haug S, Anliker M, Köberle D. Dermatologische Nebenwirkungen der EGFR-Inhibitoren. TMJ 2008; 2008:7-11.
16.02.2008Dermatologische Nebenwirkungen der EGFR-Inhibitoren
16.02.2008TMJ 2008; 2008:7-11
Haug Suanne, Anliker Mark, Köberle Dieter
Excruciating thigh pain and hepatic air collection
Köberle D, Peter I, Boggian K. Excruciating thigh pain and hepatic air collection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:1591-2, 1644-5.
15.12.2007Excruciating thigh pain and hepatic air collection
15.12.2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:1591-2, 1644-5
Köberle Dieter, Peter Irene, Boggian Katia
Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?
Ruhstaller T, Thürlimann B, Köberle D, von Moos R. Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?. JCO 2007; 25:4025-6; author reply 4026-7.
01.09.2007Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma?
01.09.2007JCO 2007; 25:4025-6; author reply 4026-7
Ruhstaller Thomas, Thürlimann Beat, Köberle Dieter, von Moos Roger
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research
Roth A, de Braud F, Seymour M, Widmer L, Glynne-Jones R, Leslie M, Wernli M, Maibach R, Rufibach K, Borner M, Köberle D, Saletti P, Bernhard J, Falk S, Stupp R, Fazio N, Swiss Group for Clinical Cancer Research. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007; 25:3217-23.
01.08.2007Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research
01.08.2007Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007; 25:3217-23
Roth Arnaud D, de Braud Filippo, Seymour Matthew, Widmer Lukas, Glynne-Jones Robert, Leslie Martin, Wernli Martin, Maibach Rudolf, Rufibach Kaspar, Borner Markus M, Köberle Dieter, Saletti Piercarlo, Bernhard Jürg, Falk Stephen, Stupp Roger, Fazio Nicola, Swiss Group for Clinical Cancer Research
Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer
Klaeser B, Wiederkehr O, Köberle D, Mueller A, Bubeck B, Thürlimann B. Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer. Ann Oncol 2007; 18:1329-34.
01.08.2007Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer
01.08.2007Ann Oncol 2007; 18:1329-34
Klaeser B, Wiederkehr O, Köberle Dieter, Mueller A, Bubeck B, Thürlimann Beat
Combining chemotherapy and low-molecular-weight heparin for the treatment of advanced breast cancer: results on clinical response, transforming growth factor-beta 1 and fibrin monomer in a phase II study
Seeholzer N, Thürlimann B, Köberle D, Hess D, Korte W. Combining chemotherapy and low-molecular-weight heparin for the treatment of advanced breast cancer: results on clinical response, transforming growth factor-beta 1 and fibrin monomer in a phase II study. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007; 18:415-23.
01.07.2007Combining chemotherapy and low-molecular-weight heparin for the treatment of advanced breast cancer: results on clinical response, transforming growth factor-beta 1 and fibrin monomer in a phase II study
01.07.2007Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007; 18:415-23
Seeholzer Niels, Thürlimann Beat, Köberle Dieter, Hess Dagmar, Korte Wolfgang
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Herrmann R, Stemmer S, Tàmas K, Kornek G, Köberle D, Cina S, Bernhard J, Dietrich D, Scheithauer W, Swiss Group for Clinical Cancer Research, Mingrone W, Köhne C, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, Saletti P, Bauer J, Figer A, Pestalozzi B, Central European Cooperative Oncology Group. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007; 25:2212-7.
01.06.2007Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
01.06.2007Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007; 25:2212-7
Herrmann Richard, Stemmer Salomon M, Tàmas Karin, Kornek Gabriela V, Köberle Dieter, Cina Susanne, Bernhard Jürg, Dietrich Daniel, Scheithauer Werner, Swiss Group for Clinical Cancer Research, Mingrone Walter, Köhne Claus-Henning, Bodoky György, Ruhstaller Thomas, Glimelius Bengt, Bajetta Emilio, Schüller Johannes, Saletti Piercarlo, Bauer Jean, Figer Arie, Pestalozzi Bernhard, Central European Cooperative Oncology Group
Adjuvante Therapie des Kolonkarzinoms
Greuter S, Jörger M, Köberle D. Adjuvante Therapie des Kolonkarzinoms. Onkologie 2007; 3:20-24.
01.01.2007Adjuvante Therapie des Kolonkarzinoms
01.01.2007Onkologie 2007; 3:20-24
Greuter S, Jörger Markus, Köberle Dieter
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)
Hess D, Ribi K, Ballabeni P, Schuller J, Rauch D, Rochlitz C, Mattmann S, Schonenberger A, Pagani O, Thürlimann B, Köberle D, Swiss Group for Clinical Cancer Research. Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99). Oncology 2007; 73:228-37.
01.01.2007Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)
01.01.2007Oncology 2007; 73:228-37
Hess Dagmar, Ribi K, Ballabeni P, Schuller J C, Rauch D, Rochlitz C, Mattmann S, Schonenberger A, Pagani O, Thürlimann Beat, Köberle Dieter, Swiss Group for Clinical Cancer Research
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Perey L, Goldhirsch A, Köberle D, Clément P, Dietrich D, Fiche M, Wildiers H, Nolé F, Zaman K, Hawle H, Paridaens R, Thürlimann B. Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00). Ann Oncol 2007; 18:64-9.
01.01.2007Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
01.01.2007Ann Oncol 2007; 18:64-9
Perey L, Goldhirsch A, Köberle Dieter, Clément P, Dietrich D, Fiche M, Wildiers H, Nolé F, Zaman K, Hawle H, Paridaens R, Thürlimann Beat
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
Köberle D, Thürlimann B. Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98. Breast Cancer Res Treat 2007; 105 Suppl 1:55-66.
01.01.2007Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
01.01.2007Breast Cancer Res Treat 2007; 105 Suppl 1:55-66
Köberle Dieter, Thürlimann Beat
Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations
Thürlimann B, Köberle D, Senn H. Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations. EJC 2007; 43:46-52.
01.01.2007Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations
01.01.2007EJC 2007; 43:46-52
Thürlimann Beat, Köberle Dieter, Senn Hans-Joerg
Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
Köberle D, Thürlimann B. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer. Expert review of anticancer therapy 2006; 6:5-10.
01.01.2006Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
01.01.2006Expert review of anticancer therapy 2006; 6:5-10
Köberle Dieter, Thürlimann Beat
Adjuvant endocrine therapy in postmenopausal breast cancer patients
Köberle D, Thürlimann B. Adjuvant endocrine therapy in postmenopausal breast cancer patients. Breast (Edinburgh, Scotland) 2005; 14:446-51.
01.12.2005Adjuvant endocrine therapy in postmenopausal breast cancer patients
01.12.2005Breast (Edinburgh, Scotland) 2005; 14:446-51
Köberle Dieter, Thürlimann Beat
Von Hippel-Lindau disease--a rare disease important to recognize
Jörger M, Köberle D, Neumann H, Gillessen Sommer S. Von Hippel-Lindau disease--a rare disease important to recognize. Onkologie 2005; 28:159-63.
01.03.2005Von Hippel-Lindau disease--a rare disease important to recognize
01.03.2005Onkologie 2005; 28:159-63
Jörger Markus, Köberle Dieter, Neumann Hartmut P H, Gillessen Sommer Silke